BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

EMD Group (EMD Serono Research Institute (Billerica)) 

45A Middlesex Turnpike

Billerica  Massachusetts  01821  U.S.A.
Phone: 978-294-1100 Fax: n/a


SEARCH JOBS

Overview
At the EMD Group, around 40,000 people in more than 60 countries develop pharmaceutical and chemical innovations. In 2010 the company generated total revenues of EUR 9.3 billion. It is the world’s oldest pharmaceutical and chemical company with roots dating back to 1668. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

From the start of industrial production in 1827, to initial research on liquid crystals more than 100 years ago, up to our entry into targeted cancer therapy with the launch of Erbitux®, many milestones in our history provide strong evidence of the pioneering spirit of the people at EMD. From innovative drugs to treat multiple sclerosis, cold remedies to new technologies for energy-efficient light sources our pioneering spirit in research and our experience enable us to develop products that improve quality of life.

Since going public in 1995, the company’s operating activities are under the umbrella of Merck KGaA Darmstadt, Germany.

Career Opportunities
Do you want to continue to experiment, analyze and break new ground? Welcome to EMD. When it comes to innovations, you will find us in the front ranks. And the breadth of our ceative research is far-reaching: from medicines, through opportunities in bio-research and bio-production, all the way to liquid crystals for LCDs. Enough latitude, in other words, to make your passion a true calling. Bring us entrepreneurial flair, plenty of team spirit and a total commitment to delivering the best possible results for our customers, and you’ll go far. You’ll enjoy all the interest and exposure of working in multidisciplinary, international teams. Depending on your field of expertise, you may even have the chance to develop across business sectors and functions.

To find out where you could go in an organization that’s part of Merck KGaA, Darmstadt, Germany, a global force in chemicals and pharmaceuticals with operations in more than countries and revenues of €9.3 billion in 2010, please visit come2emd.com.

EMD Group is an Equal Opportunity Employer.

Products:
Pharmaceuticals
EMD Serono is the largest division of the EMD Group and discovers, develops, manufactures and commercializes innovative prescription drugs and therapies for high unmet medical needs. The focus lies in specialist therapeutic areas such as oncology, multiple sclerosis and infertility. Through their targeted effect, these medicines help patients to live a longer and better life. Many consumers around the world trust a wide range of well-known brands that EMD develops, manufactures and markets for the OTC (over-thecounter) pharmaceutical sector.

Chemicals
Our broad range of specialty chemicals are used in technologically sophisticated applications ranging from liquid crystal, to effect pigments and cosmetic ingredients. The EMD Group is the global leader in the liquid crystals market. Liquid crystals are used throughout the world, in LCD TVs, monitors, tablet computers, notebooks, mobile phones, and digital cameras. In addition to the display materials business, the Performance Materials division focuses on materials for energy-saving lighting using LEDs (light-emitting diodes) and OLEDs (organic LEDs). Pigments for the plastics, printing and coatings industries as well as for cosmetic applications are an important part of the Performance Materials portfolio. Moreover, the division is the market leader for pearl-luster effect pigments.

With the EMD Millipore division, the EMD Group is a leading life science company, which offers products, applications and solutions for protein research and cell biology as well as for the manufacture of chemical-based and biopharmaceutical drugs. The portfolio comprises products for life science research such as assays, biomarkers and targeted solutions, as well as bioprocessing, lab water purification and filtration. Additionally, the division supplies specialty chemicals mainly to regulated markets, for example the pharmaceutical, cosmetics and food industries. Analytical and scientific laboratories use the reagents and test kits supplied by the division. The EMD Millipore portfolio comprises more than 40,000 products and processes.
Thank you in advance! I am looking forward to hearing from you.


 Key Statistics


Email:
Ownership: Private

Web Site: EMD Group (EMD Serono Research Institute (Billerica))
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
EMD Serono, Inc. (Billerica) Founding Donor of Newly Launched MGH Multiple Sclerosis Discovery Forum 4/17/2012 10:08:20 AM    More...
EMD Serono, Inc. (Billerica) and Fast Forward, LLC Commit $3 Million for Multiple Sclerosis 10/19/2011 10:50:40 AM    More...
EMD Serono, Inc. (Billerica) Honored as a 2011 Working Mother 100 Best Company 9/15/2011 10:30:48 AM    More...
EMD Serono, Inc. (Billerica) Committed to Transparency in Interactions with Healthcare Professionals and Organizations 6/23/2011 8:48:23 AM    More...
EMD Serono, Inc. (Billerica)’s Commitment to Advance Multiple Sclerosis Care and Research Underscored by Data to Be Presented at AAN 2011 Meeting 4/8/2011 8:22:33 AM    More...
EMD Serono, Inc. Receives CEO Cancer Gold StandardTM Accreditation 3/24/2011 8:08:11 AM    More...
CIGNA Corporation and EMD Serono Team to Fight Multiple Sclerosis Under First Outcomes-Based Specialty Medication Contract 3/17/2011 9:11:12 AM    More...
CIGNA Corporation and EMD Serono Team to Fight Multiple Sclerosis Under First Outcomes-Based Specialty Medication Contract 3/16/2011 10:51:23 AM    More...
Merck KGaA (MKGAF.PK)'s EMD Serono, Inc. (Billerica)'s MS Drug Cladribine Rejected by FDA 3/2/2011 6:53:15 AM    More...
EMD Serono, Inc. (Billerica) Holds Grand Opening Ceremony for New State-of-the-Art Research Center in Billerica, MA 2/10/2011 7:21:06 AM    More...
1234

//-->